|
Aerolate JrDrug - Aerolate Jr The trade name of the product as shown on the labeling.
Dosage -
CAPSULE, EXTENDED RELEASE; ORAL
Active Ingredient(s) -
Theophylline
Strength -
130MG
Applicant -
FLEMING PHARMS
New Drug Application (NDA) Number -
085075
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Nov 24, 1986
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Fleming And Co Pharmaceuticals Inc
Aerolate Jr
Thalomid 50mg Capsule; Oral
Thallous Chloride Tl 201 1mci/ml Injectable; Injection Thallous Chloride Tl 201 1mci/ml Injectable; Injection Thallous Chloride Tl 201 1mci/ml Injectable; Injection Thallous Chloride Tl 201 1mci/ml Injectable; Injection Thallous Chloride Tl 201 1mci/ml Injectable; Injection Thallous Chloride Tl 201 2mci/ml Injectable; Intravenous Aerolate Iii 65mg Capsule, Extended Release; Oral Aerolate Jr 130mg Capsule, Extended Release; Oral Thalomid 200mg Capsule; Oral NewDrugInformation |